by njbioindia | Nov 6, 2023 | Uncategorized
NJ Bio, Inc., was awarded the Best Contract Research Organization Award at the 10th Annual World ADC Awards NJ Bio, Inc., is delighted to announce its recent honor as the recipient of the “Best Contract Research Organization” (CRO) Award at the 10th Annual World ADC...
by njbioindia | Oct 27, 2023 | Uncategorized
NJ Bio, Inc., presented the siteDAR© tool for ADC characterization, at the 14th Annual World ADC Conference NJ Bio, Inc., took the global stage at the 14th Annual World ADC conference, shedding light on a prevalent challenge in the world of Antibody-Drug Conjugates...
by njbioindia | Oct 4, 2023 | Uncategorized
NJ Bio, Inc. was thrilled to learn how to “Break Barriers” from Dr. Seema Kantak, a passionate cancer biologist and scientific leader. NJ Bio, Inc., had the privilege of hosting Senior Vice President, Head of Biologics & Biotherapeutics at Exelixis, Inc., Dr....
by njbioindia | Sep 27, 2023 | Uncategorized
NJ Bio, Inc., is honored to be shortlisted a fourth consecutive time for the title of “Best Contract Research Organization” at the World ADC Awards. The World ADC Awards is a platform that acknowledges creativity, innovation, leadership and devotion in the field of...
by njbioindia | Jun 20, 2023 | Uncategorized
Kiran Mazumdar Shaw inaugurates NJ Bio’s new “Center for NMR Excellence” at headquarters in Princeton is thrilled to share that the Honorable Ms. Kiran Mazumdar Shaw inaugurated the “Center for NMR Excellence” equipped with the state-of-the-art JEOL 800 MHz and...
